Inhibition of platelet aggregation by clopiclogrel is unaffected by the CYP2C19 681G>A polyrnorphism in patients with coronary artery disease

被引：0
|
作者：
Smith, Simon M. G. [1 ]
Buckland, Robert [1 ]
Daly, Martina E. [1 ]
Storey, Robert F. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：375A / 375A
页数：1
相关论文
共 50 条
  • [41] The role of clinical parameters and of CYP2C19 G681 and CYP4F2 G1347A polymorphisms on platelet reactivity during dual antiplatelet therapy
    Tatarunas, Vacis
    Jankauskiene, Laima
    Kupstyte, Nora
    Skipskis, Vilius
    Gustiene, Olivija
    Grybauskas, Pranas
    Lesauskaite, Vaiva
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (04) : 369 - 374
  • [42] Analysis of the Guiding Role of CYP2C19 Gene Combined With Platelet Function Detection in Antiplatelet Therapy in Patients With Complex Coronary Artery Disease After PCI
    Yu, Jiancai
    Liu, Yongxing
    Peng, Wanzhong
    Liu, Juan
    Li, Ya
    Liu, Junyan
    Jiang, Yang
    Liu, Demin
    Xu, Zesheng
    FRONTIERS IN SURGERY, 2022, 9
  • [43] Impact of CYP2C19 genotype status on clinical outcomes in patients with symptomatic coronary artery disease, stroke, and peripheral arterial disease
    Maas, D.
    Willems, L.
    Kranendonk, J.
    Kramers, C.
    Warle, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [44] Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study
    Ogawa, Hisao
    Isshiki, Takaaki
    Kimura, Takeshi
    Yokoi, Hiroyoshi
    Nanto, Shinsuke
    Takayama, Morimasa
    Kitagawa, Kazuo
    Nishikawa, Masakatsu
    Miyazaki, Shunichi
    Ikeda, Yasuo
    Nakamura, Masato
    Tanaka, Yuko
    Saito, Shigeru
    JOURNAL OF CARDIOLOGY, 2016, 68 (1-2) : 29 - 36
  • [45] The CYP2C19*2 and CYP2C19*3 Polymorphisms; Are Associated with High Posttreatment Platelet Reactivity in Patients with Acute Myocardial Infarction.
    Jeong, Young-Hoon
    Kim, In-Suk
    Kwak, Choong Hwan
    Hwang, Jin-Yong
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (9A): : 82B - 82B
  • [46] The Influence of Omeprazole on Platelet Inhibition of Clopidogrel in Various CYP2C19 Mutant Alleles
    Liu, Qian
    Dang, Da-Sheng
    Chen, Yu-Feng
    Yan, Ming
    Shi, Guo-Bing
    Zhao, Qing-Chun
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (11) : 1293 - 1297
  • [47] Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients
    Nicolas Simon
    Jonathan Finzi
    Guillaume Cayla
    Gilles Montalescot
    Jean-Philippe Collet
    Jean-Sébastien Hulot
    European Journal of Clinical Pharmacology, 2015, 71 : 1059 - 1066
  • [48] Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease
    Erlinge, David
    James, Stefan
    Duvvuru, Suman
    Jakubowski, Joseph A.
    Wagner, Henrik
    Varenhorst, Christoph
    Tantry, Udaya S.
    Brown, Patricia B.
    Small, David
    Moser, Brian A.
    Sundseth, Scott S.
    Walker, Joseph R.
    Winters, Kenneth J.
    Gurbel, Paul A.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 943 - 950
  • [49] The effect of the CYP2C19*2 allele on cardiovascular outcomes in patients with coronary artery stenting: a prospective study
    Yang, Dahao
    Peng, Changnong
    Liao, Zhiyong
    Wang, Xiaoqing
    Guo, Wenyu
    Li, Jun
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (04) : 837 - 844
  • [50] Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients
    Simon, Nicolas
    Finzi, Jonathan
    Cayla, Guillaume
    Montalescot, Gilles
    Collet, Jean-Philippe
    Hulot, Jean-Sebastien
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (09) : 1059 - 1066
12345